Skip to main content

We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.

Join Now
Sign In

Member Sign In

Username or Email Address

Password

Keep Me Signed In What does "Remember Me" do?

Don't Know Your Password?
Help

Join Now
Sign In

Member Sign In

Username or Email Address

Password

Keep Me Signed In

Don't Know Your Password?

Zacks

more

Flora Growth (FLGC)

(Delayed Data from NSDQ)

$1.24 USD

-0.01 (-0.80%)

Updated May 30, 2024 04:00 PM ET

After-Market: $1.26 +0.02 (1.61%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.08%
2	Buy	17.91%
3	Hold	9.44%
4	Sell	5.10%
5	Strong Sell	2.55%
S&P	500	11.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

Top 40% (100 out of 250)

Industry: Medical - Products

View All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

4 items in cart

View Cart/Checkout

Flora Growth Corp. [FLGC]

Reports for Purchase

Showing records 21 - 40 ( 46 total )

Company: Flora Growth Corp.

Industry: Medical - Products

Record: 21

07/12/2022

Pages: 3

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Analyst: Research Department

Price: 5.00

Research Provided by a Third Party

Company: Flora Growth Corp.

Industry: Medical - Products

Record: 22

07/12/2022

Pages: 4

New CFO Brings E-Commerce Expertise, & Colombia Moves Toward Legalization

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 5.00

Research Provided by a Third Party

Company: Flora Growth Corp.

Industry: Medical - Products

Record: 23

06/27/2022

Industry Report

Pages: 10

Weekly ReHash: California at Inflection on Easing Regulations & Improved Access

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 12.50

Research Provided by a Third Party

Company: Flora Growth Corp.

Industry: Medical - Products

Record: 24

06/23/2022

Pages: 3

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Analyst: Research Department

Price: 5.00

Research Provided by a Third Party

Company: Flora Growth Corp.

Industry: Medical - Products

Record: 25

06/23/2022

Pages: 7

Cheap Valuation, U.S. Core JustCBD + Vessel Bridges Business, Reit Buy

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 12.50

Research Provided by a Third Party

Company: Flora Growth Corp.

Industry: Medical - Products

Record: 26

06/17/2022

Pages: 3

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Analyst: Research Department

Price: 5.00

Research Provided by a Third Party

Company: Flora Growth Corp.

Industry: Medical - Products

Record: 27

06/16/2022

Pages: 4

Announces $5M Share Buyback, Clears Lockup Shares & Indicates Confidence

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 5.00

Research Provided by a Third Party

Company: Flora Growth Corp.

Industry: Medical - Products

Record: 28

05/11/2022

Pages: 5

2021 Results, Integrating & Scaling CPG Segments, Buy and PT to $5

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 5.00

Research Provided by a Third Party

Company: Flora Growth Corp.

Industry: Medical - Products

Record: 29

05/11/2022

Pages: 4

MID-DAY SUMMARY

Provider: Roth Capital Partners, Inc.

Analyst: Research Department

Price: 5.00

Research Provided by a Third Party

Company: Flora Growth Corp.

Industry: Medical - Products

Record: 30

05/09/2022

Pages: 6

Cannabis Earnings 1Q22: Week II Preview

Provider: Roth Capital Partners, Inc.

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: Flora Growth Corp.

Industry: Medical - Products

Record: 31

04/06/2022

Pages: 3

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Analyst: Research Department

Price: 5.00

Research Provided by a Third Party

Company: Flora Growth Corp.

Industry: Medical - Products

Record: 32

04/05/2022

Pages: 4

Reaffirms Readiness To Export Dry Flower Following Colombian Legislation

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 5.00

Research Provided by a Third Party

Company: Flora Growth Corp.

Industry: Medical - Products

Record: 33

03/25/2022

Industry Report

Pages: 8

Weekly ReHash: NJ and NY Conversion Catalyst Fueling M&A

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 12.50

Research Provided by a Third Party

Company: Flora Growth Corp.

Industry: Medical - Products

Record: 34

03/17/2022

Pages: 5

Leading Conference Idea, Raising Estimates and Several Upside Avenues

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 5.00

Research Provided by a Third Party

Company: Flora Growth Corp.

Industry: Medical - Products

Record: 35

03/17/2022

Pages: 4

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Analyst: Research Department

Price: 5.00

Research Provided by a Third Party

Company: Flora Growth Corp.

Industry: Medical - Products

Record: 36

03/11/2022

Pages: 9

Company Update, US CBD, Colombia,Israel, and Vessel Management Takeaways

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 12.50

Research Provided by a Third Party

Company: Flora Growth Corp.

Industry: Medical - Products

Record: 37

03/11/2022

Pages: 3

MID-DAY SUMMARY

Provider: Roth Capital Partners, Inc.

Analyst: Research Department

Price: 5.00

Research Provided by a Third Party

Company: Flora Growth Corp.

Industry: Medical - Products

Record: 38

02/16/2022

Industry Report

Pages: 41

Consumer-LT Growth Story Intact, NT Headwinds Expected

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 50.00

Research Provided by a Third Party

Company: Flora Growth Corp.

Industry: Medical - Products

Record: 39

01/21/2022

Industry Report

Pages: 8

Weekly ReHash: California To See Lots of Changes in 2022, Positive Developments

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 12.50

Research Provided by a Third Party

Company: Flora Growth Corp.

Industry: Medical - Products

Record: 40

01/04/2022

Pages: 4

Expands Distribution into Mexico, Becoming a Global Cannabis/CPG Player

Provider: Roth Capital Partners, Inc.

Analyst: FORTUNE S

Price: 5.00

Research Provided by a Third Party